# Antimicrobial susceptibility of Porphyromonas spp. isolated from dogs with periodontal disease in South Korea

**Authors:** Taesoo Kim, Yi-Don Choi, Won Hur, Sang-Won Lee, Tae-Min La

PMC · DOI: 10.3389/fvets.2025.1684907 · Frontiers in Veterinary Science · 2025-11-10

## TL;DR

This study examines the antibiotic resistance of Porphyromonas bacteria in dogs with gum disease in South Korea.

## Contribution

The study provides new data on antimicrobial susceptibility of Porphyromonas spp. in canine periodontal disease.

## Key findings

- 15% of isolates showed resistance to penicillin and 25% to clindamycin.
- No resistance was observed to several antibiotics like metronidazole and tetracycline.
- The study identified five Porphyromonas species from 30 out of 58 dogs.

## Abstract

Porphyromonas spp. are oral anaerobes that play a key role in the pathogenesis of canine periodontal disease. Despite their clinical relevance in veterinary medicine, data on the antimicrobial susceptibility of canine Porphyromonas isolates remain limited. Therefore, we assessed the antimicrobial susceptibility of Porphyromonas spp. isolated from the subgingival plaque of dogs with periodontitis in South Korea. Fifty-eight dogs diagnosed with periodontal disease were screened for Porphyromonas spp., and species identification was confirmed using PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Antimicrobial susceptibility testing was performed using the broth microdilution method with the Sensititre AN02B panel. Overall, 40 isolates were recovered from 30 of the 58 dogs sampled, comprising 15 Porphyromonas gulae, 11 Porphyromonas macacae, eight Porphyromonas gingivalis, five Porphyromonas gingivicanis, and one Porphyromonas crevioricanis. Resistance was detected in six isolates (15%) to penicillin, three (7.5%) to imipenem, three (7.5%) to meropenem, 15 (25%) to clindamycin, and seven (17.5%) to ampicillin. No resistance was observed to ampicillin/sulbactam, amoxicillin/clavulanic acid, cefotetan, cefoxitin, metronidazole, chloramphenicol, piperacillin, tetracycline, mezlocillin, or piperacillin/tazobactam. These findings provide crucial insights into the antimicrobial susceptibility patterns of canine oral Porphyromonas spp. and highlight the importance of judicious antimicrobial use in veterinary dentistry.

## Linked entities

- **Chemicals:** penicillin (PubChem CID 2349), imipenem (PubChem CID 104838), meropenem (PubChem CID 441130), clindamycin (PubChem CID 446598), ampicillin (PubChem CID 6249), ampicillin/sulbactam (PubChem CID 119561), amoxicillin/clavulanic acid (PubChem CID 6435924), cefotetan (PubChem CID 53025), cefoxitin (PubChem CID 441199), metronidazole (PubChem CID 4173), chloramphenicol (PubChem CID 5959), piperacillin (PubChem CID 43672), tetracycline (PubChem CID 54675776), mezlocillin (PubChem CID 656511), piperacillin/tazobactam (PubChem CID 461573)
- **Diseases:** periodontal disease (MONDO:0002635)
- **Species:** Porphyromonas gulae (taxon 111105), Porphyromonas macacae (taxon 28115), Porphyromonas gingivalis (taxon 837), Porphyromonas gingivicanis (taxon 266762), Porphyromonas crevioricanis (taxon 393921)

## Full-text entities

- **Diseases:** periodontal disease (MESH:D010510), periodontitis (MESH:D010518)
- **Chemicals:** ampicillin (MESH:D000667), amoxicillin/clavulanic acid (MESH:D019980), cefotetan (MESH:D015313), penicillin (MESH:D010406), metronidazole (MESH:D008795), cefoxitin (MESH:D002440), tetracycline (MESH:D013752), mezlocillin (MESH:D008802), piperacillin (MESH:D010878), clindamycin (MESH:D002981), ampicillin/sulbactam (MESH:C035444), chloramphenicol (MESH:D002701), meropenem (MESH:D000077731), piperacillin/tazobactam (MESH:D000077725), imipenem (MESH:D015378)
- **Species:** Porphyromonas gulae (species) [taxon 111105], Porphyromonas crevioricanis (species) [taxon 393921], Porphyromonas gingivalis (species) [taxon 837], Canis lupus familiaris (dog, subspecies) [taxon 9615], Porphyromonas gingivicanis (species) [taxon 266762], Porphyromonas macacae (species) [taxon 28115]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640808/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640808/full.md

---
Source: https://tomesphere.com/paper/PMC12640808